- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4773
10-year publication summary
|
338
|
275
|
302
|
352
|
291
|
250
|
238
|
265
|
214
|
220
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2721 |
96 |
| Janssen Pharmaceutica N.V. | 3358 |
95 |
| Merck Sharp & Dohme LLC | 3732 |
78 |
| Boehringer Ingelheim International GmbH | 4636 |
72 |
| F. Hoffmann-La Roche AG | 7937 |
69 |
| Bristol-myers Squibb Company | 4826 |
68 |
| Novartis AG | 10612 |
65 |
| VALO Health, Inc. | 176 |
53 |
| Merck Patent GmbH | 5752 |
40 |
| The Regents of the University of California | 20303 |
37 |
| Syngenta Crop Protection AG | 6259 |
36 |
| Eli Lilly and Company | 3926 |
36 |
| Allergan, Inc. | 2313 |
34 |
| Centre National de La Recherche Scientifique | 10706 |
34 |
| Toray Industries, Inc. | 7015 |
32 |
| ChemoCentryx, Inc. | 379 |
32 |
| Mycovia Pharmaceuticals, Inc. | 40 |
32 |
| Hoffmann-La Roche Inc. | 3546 |
29 |
| AstraZeneca AB | 2857 |
29 |
| Astellas Pharma Inc. | 1057 |
29 |
| Other owners | 3777 |